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Abstract: Small intestinal Paneth cells, enteric glial cells (EGC), and goblet cells maintain gut mucosal
integrity, homeostasis, and influence host physiology locally and through the gut-brain axis. Little is
known about their roles during pregnancy, or how maternal malnutrition impacts these cells and
their development. Pregnant mice were fed a control diet (CON), undernourished by 30% vs. control
(UN), or fed a high fat diet (HF). At day 18.5 (term = 19), gut integrity and function were assessed
by immunohistochemistry and qPCR. UN mothers displayed reduced mRNA expression of Paneth
cell antimicrobial peptides (AMP; Lyz2, Reg3g) and an accumulation of villi goblet cells, while HF
had reduced Reg3g and mucin (Muc2) mRNA and increased lysozyme protein. UN fetuses had
increased mRNA expression of gut transcription factor Sox9, associated with reduced expression of
maturation markers (Cdx2, Muc2), and increased expression of tight junctions (TJ; Cldn-7). HF fetuses
had increased mRNA expression of EGC markers (S100b, Bfabp, Plp1), AMP (Lyz1, Defa1, Reg3g),
and TJ (Cldn-3, Cldn-7), and reduced expression of an AMP-activator (Tlr4). Maternal malnutrition
altered expression of genes that maintain maternal gut homeostasis, and altered fetal gut permeability,
function, and development. This may have long-term implications for host-microbe interactions,
immunity, and offspring gut-brain axis function.
Keywords: malnutrition; gut barrier; development; pregnancy
1. Introduction
The gut is critical to host health and disease development through interactions with microbes
that colonize the gut and establishment of the gut epithelial barrier [1,2]. Major gut functions include
absorption of water and nutrients; secretion of digestive enzymes, bile, and mucus; and motility
of luminal contents down the gastrointestinal tract and in a mixing motion to ensure adequate
contact with the epithelium for absorption [3]. In health, the gut is involved in vitamin synthesis [4],
nutrient metabolism [5], and protection against pathogens [1,6]. It is also important for brain function:
a direct and bidirectional channel of communication exists between the gut and the brain, dubbed the
gut-brain axis, which includes a connection between the enteric and central nervous systems (CNS) [7].
Microbes that reside in the gut, their metabolites [8], hormones [9], and immune factors [10], have been
shown to affect gut and brain function through this axis in humans and animals [7]. Since microbes
and the metabolites they produce can activate host immune, metabolic, and stress pathways once they
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leave the gut environment [11], an important part of the gut-microbe-host relationship is the separation
between the gut tissue, the gut ecosystem, and the rest of the host.
This separation is mediated by the intestinal epithelial barrier, which lies at the interface between
exogenous host factors and the internal gut microenvironment and helps to regulate microbe-host
interactions. During periods of optimal nutrition and host health, two key cell types are involved in
supporting and maintaining this gut barrier: Paneth cells and enteric glial cells (EGCs). Paneth cells
reside in the epithelium of the small intestine (SI), maintain gut integrity and prevent microbial
translocation through production of tight junction (TJ) proteins [12], and produce antimicrobial peptides
(AMPs) which regulate the host-microbe relationship [13]. As well, due to their proximity to crypt
stem cells [14,15], Paneth cells can affect gut epithelial cell differentiation and gut maturation [14,15].
Toll-like receptors (TLRs), which activate the innate immune response when bacterial components
are recognized in the gut environment, are purported to play a key role in inducing Paneth AMP
production [16]. In addition, EGCs are part of the enteric nervous system (ENS) and gut-brain
axis [17], and respond to and control gut inflammation [18,19]. EGCs also influence gut integrity
and permeability [20] through their long cytoplasmic processes which make direct contact with the
barrier [21]. Other enteric cells, such as goblet cells, maintain gut barrier integrity through their
production of mucus [12]. Importantly, Paneth cells and EGCs are established in early development
(Figure S1) [14,22], suggesting they are key for early and lifelong gut and brain health.
The integrity of the gut barrier and the composition and function of the gut microbiome can
be greatly affected by the diet of the host [23–25], since the indigestible polysaccharides in the
host diet become gut bacterial substrates and nutrients [26]. Indeed, adaptations to gut bacterial
metabolism and transcription occur within days of dietary changes in humans [24]. In response to
both over- [27] and undernutrition [28], collectively known as malnutrition, gut barrier function and
integrity can become dysregulated, leading to gut microbial dysbiosis, altered gut function, and a leaky
gut barrier. Yet, few studies have elucidated the effects of malnutrition on Paneth cell [29–33] and
EGC [34,35] development and function (indeed, none have examined EGCs during undernutrition
to our knowledge), or how either of these cells are affected by and/or perpetuate gut dysfunction.
Since the rates of both undernutrition and underweight [36], as well as over-nutrition and obesity [36],
are increasing worldwide, and a compromised gut barrier is both caused by, and leads to, a variety
of immune-related, and chronic diseases, the effects of malnutrition on the gut-host relationship are
important to understand.
During pregnancy, the intestinal epithelial barrier and the microbes contained within the gut are
doubly important, as they protect both the mother and, by association, the fetus from harmful bacteria
and xenobiotics [1,37], produce nutrients required for pregnancy health [38], and absorb nutrients into
the blood stream that are vital to fetal development [39,40]. We and others have shown that maternal
malnutrition impacts the maternal gut microbiome [41–44] and is associated with increased levels
inflammation in the maternal gut and peripheral circulation [41,44]. In offspring, a mature intestinal
epithelial barrier ensures a healthy and homeostatic gut environment [45], which allows the offspring to
appropriately respond to infections [45], absorb and produce nutrients [16], and likely establish optimal
communication with the brain and other organs [7]. Still, little is known about how malnutrition
impacts the maternal epithelial barrier during pregnancy, a ‘stress-test’ in itself, or whether maternal
malnutrition adversely programmes fetal gut development and function. Additionally, although we
know that Paneth cells [14] and EGCs [46,47] are laid down and functional in early life, we know
less about how early life adversity, including poor nutrition, or gut microbes, may influence their
development and function.
We therefore sought to answer two questions: how does malnutrition during pregnancy affect
maternal gut barrier function, and does maternal malnutrition impact fetal gut integrity, function,
and development? We focused on Paneth cells and EGCs to answer these questions as these cells
may be critical for long-term gut function and communication with the brain. We hypothesized that
malnutrition would lead to an adverse maternal gut environment, and that mothers fed a high fat (HF)
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diet and their offspring would display the most affected gut function, since our previous work has
demonstrated that the maternal gut is especially affected by a HF diet [41]. We also hypothesized that,
due to the changes in maternal diets and gut environments, the fetal gut would display aberrant gut
integrity and function and EGC development, with different outcomes in fetuses from undernourished
(UN) and HF mothers.
2. Materials and Methods
2.1. Animal Model
All housing and breeding procedures were approved by the Animal Care Committee at Mount Sinai
Hospital (Toronto, ON, Canada; AUP 16-0091H). Male and female C57BL/6J mice (Jackson Laboratories,
Bar Harbor, ME, USA) were housed using a 12:12 light:dark cycle at 25 ◦C, with free access to food and
water. Females were randomized into three diet groups: mice fed control diet ad libitum before and
throughout pregnancy (CON, n = 7); mice fed control diet ad libitum before mating and undernourished
by 30% from gestational day (d) 5.5 to 17.5 (UN, n = 7); and mice fed high fat diet (60% of calories
as fat) ad libitum from 8 weeks prior to mating and through pregnancy (HF, n = 8). Males were fed
control diet ad libitum and mated with females at ~10 weeks of age. Females were housed individually
following confirmation of pregnancy status (presence of vaginal sperm plug). Dams were weighed
weekly before and daily during pregnancy.
2.2. Maternal SI and Fetal Gut Collection
Dams were sacrificed by cervical dislocation at d18.5 (term = d19). Fetuses were collected,
weighed, and at random, one male and female fetus from each litter was used for fetal biospecimen
collections. Maternal and fetal gastrointestinal (GI) tracts were dissected as detailed previously [41].
A 2–5 mm piece of maternal SI from the mid portion of the SI (representing the jejunum) and
the entire fetal gut were flash frozen in liquid nitrogen then stored at −80 ◦C for later molecular
analyses. Another 2–5 mm of maternal SI from the mid portion was flushed with buffered 4%
paraformaldehyde (PFA), cut longitudinally, and cut into two pieces for fixing in 4% PFA at 4 ◦C
overnight. Fixed SI were washed thrice with 1× PBS and stored in 70% ethanol until paraffin embedded
for later immunohistochemical analyses.
2.3. RNA Extraction and mRNA Expression Analysis
Total RNA was extracted from maternal SI and fetal guts using the Tissue Lyser II (Qiagen, Hilden,
NRW, Germany) and RNA extraction kits following manufacturer’s instructions (QIAGEN RNeasy Plus
Mini Kit, Toronto, ON, Canada). Eluted RNA quality and quantity were assessed by spectrophotometry
(DeNovix, Wilmington, DE, USA), and 1 µg of RNA was reverse transcribed using 5× iScript Reverse
Transcription Supermix (Bio-Rad, Mississauga, ON, Canada).
We focused on genes involved in gut barrier function, integrity, and development to
establish how maternal malnutrition may impact the maternal gut and, by consequence, fetal gut
and ENS development (Table 1). mRNA expression data were normalized to the geometric
mean of the three stably-expressed reference genes: TATA-Box Binding Protein (Tbp), Tyrosine
3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta (Ywhaz), and Beta-actin
(Actb). Primers were designed from gene sequences found in the NCBI Nucleotide Database or taken
from the literature and analyzed using NCBI Primer-BLAST and Oligo Calc (Northwestern University,
Evanston, IL, USA) for appropriate gene targeting and properties. Amplification and detection of
mRNA expression was measured using CFX384 Touch Real-Time PCR Detection System (Bio-Rad).
Samples, standards, and controls were pipetted in triplicate. Inter-run calibrators and non-template
controls were run alongside each gene to normalize between plates and to assess contamination,
respectively. The PCR cycling conditions were: 30 s at 95 ◦C, 40 × 5 s at 95 ◦C, 20 s at 60 ◦C. Data were
analyzed applying the Pfaﬄ method [48].
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Table 1. Primer sequences for quantitative PCR.
Gene Sequence 5’–3’ Source
Gut barrier function markers
Lyz1 F-GGGAACCTGTGACCTGTCTT Accession: NM_013590.4R-GCCTCATGACACTGGGAACA
Lyz2 F-TCTACTGCAGCTCATTCGGT Accession: NM_017372.3R-CTTAGAGGGGAAATCGAGGGAA
Pla2g2 F-AGGATTCCCCCAAGGATGCCAC PMID: 19855381R-CAGCCGTTTCTGACAGGAGTTCTGG
Defa1 F-TCAAGAGGCTGCAAAGGAAGAGAAC PMID: 19855381R-TGGTCTCCATGTTCAGCGACAGC
Defa5 F-CTTGTCCTGCTGGCCTTCC Accession: NM_007851.2R-TAGACACAGCCTGGTCCTCT
Reg3g F-CCATCTTCACGTAGCAGC PMID: 22723890R-CAAGATGTCCTGAGGGC
Tlr4 Bio-Rad (Mississauga, ON, Canada) Assay ID: qMmuCID0023548
Gut barrier integrity markers
Muc2
F-ACCTGGAAGGCCCAATCAAG
Accession: NM_023566.3R-CAGCGTAGTTGGCACTCTCA
Cldn-3
F-GCACCCACCAAGATCCTCTA
PMID: 17383680R-AGGCTGTCTGTCCTCTTCCA
Cldn-7
F-CATTGTGGCAGGTCTTGCTG
Accession: NM_016887.6R-CATGGGCGTCAAGGGGTTAT
EGC maturation and function markers
Bfabp F-GGTTCGGTTGGATGGAGACA Accession: NM_021272.3R-AGTCACGACCATCTTGCCAT
S100b
F-TGGCTGCGGAAGTTGAGATT
Accession: NM_009115.3R-ATGGCTCCCAGCAGCTAAAG
Gdnf F-ACCAGTGACTCCAATATGCCTG Accession: NM_001301357.1R-CTGCCGCTTGTTTATCTGGTG
Sox10 Bio-Rad (Mississauga, ON, Canada) Assay ID: qMmuCID0007045
Plp1 Bio-Rad (Mississauga, ON, Canada) Assay ID: qMmuCED0061105
Fetal gut development markers
Cdx2
F-AGCCAAGTGAAAACCAGGAC
Accession: NM_007673.3R-AGTGAAACTCCTTCTCCAGCTC
Sox9
F-GCCACGGAACAGACTCACAT
Accession: NM_011448.4R-AGATTGCCCAGAGTGCTCG
Reference genes
Ywhaz
F-GCAACGATGTACTGTCTCTTTTGG
Accession: NM_011740.3R-GTCCACAATTCCTTTCTTGTCATC
Tbp F-CGGACAACTGCGTTGATTTTC Accession: NM_013684.3R-AGCCCAACTTCTGCACAACTC
Actb
F-TCGTGCGTGACATCAAAGAGA
Accession: NM_007393.5R-GAACCGCTCGTTGCCAATA
Lyz, Lysozyme; Pla2g2, Phospholipase A2 Group II; Defa, Alpha Defensin; Reg3g, Regenerating Family Member 3
Gamma; Tlr4, Toll-Like Receptor 4; Muc2, Mucin 2; Cldn, Claudin; Bfabp, Brain-Type Fatty Acid-Binding Protein; S100b,
S100 Calcium Binding Protein B; Gdnf, Glial-Derived Neurotrophic Factor; Sox10, SRY-Box 10; Plp1, Proteolipid
Protein 1; Cdx2, Caudal Type Homeobox 2; Sox9, SRY-Box 9; Ywhaz, Tyrosine 3-Monooxygenase/Tryptophan
5-Monooxygenase Activation Protein Zeta; Tbp, TATA-Box Binding Protein; Actb, Beta-actin; F, Forward primer; R,
Reverse primer; PMID, PubMed Identification.
2.4. Expression and Localization of Lysozyme Protein and Quantification of Goblet Cells in Maternal SI
Immunohistochemistry (IHC) was used to localize and semi-quantify immunoreactive (ir) staining
of lysozyme (Lyz) and to quantify goblet cell number. Five millimeter sections of maternal SI were cut
from paraffin-embedded blocks and mounted onto glass slides. For lysozyme staining, sections were
deparaffinized and rehydrated in descending alcohol series and quenched with 3% hydrogen peroxide
in 90% ethanol for 20 min at room temperature. Sections underwent antigen retrieval by sodium
citrate/citric acid solution and microwaved for 10 min, then blocked in serum-free protein blocking
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solution (Agilent Dako, Santa Clara, CA, USA) for 1 h at room temperature, and incubated overnight at
4 ◦C with rabbit anti-lysozyme antibody (1:200 dilution; product #PA1-29680, Thermo Fisher Scientific,
Waltham, MA, USA). Negative control sections were probed with normal rabbit IgG (0.4 µg/µL,
1:200; #sc-2027, Santa Cruz Biotechnology, Dallas, TX, USA). Sections were then incubated with goat
biotinylated anti-rabbit secondary antibody (1:200; #BA-1000, Vector Labs, Burlingame, CA, USA) for
1 h at room temperature, followed by 1 h incubation with streptavidin-horseradish peroxidase (1:2000
in 1× PBS; Invitrogen, Carlsbad, CA, USA). Antibody-antigen interactions were visualized using DAB
for 40 s (Vectastain DAB ABC kit, Vector Labs). Sections were counterstained with Gills I haematoxylin
to provide greater contrast and to stain nuclei. Semi-quantitative analyses of ir-lysozyme staining
intensity was performed using computerized image analysis (Image-Pro Plus 4.5, Media Cybernetics,
Rockville, MD, USA; and Olympus BX61 microscope, Shinjuku, Tokyo, Japan). A superimage was
composited from individual images (at 20× magnification) captured along the entire SI section from
each dam. To semi-quantitatively measure staining intensity in each image (where higher levels of
staining intensity may represent higher Lyz protein expression), an algorithm was developed (using
Visiopharm NewCAST Analysis software, Hørsholm, Denmark) to detect intensity of DAB staining for
ir-Lyz in four levels of intensity: low, moderate, high, and strong. Staining intensity for each of the
four levels was summed across all images within a superimage for each animal. CON mothers had
a mean ± SEM (range) of 10.3 ± 0.7 (7–13) images per superimage, UN had 10 ± 0.8 (7–13) images, and
HF had 9 ± 0.6 (7–12) images. There was no statistical difference between diet groups in the number of
images per superimage (p = 0.37).
For goblet cell quantification, sections were stained with alcian blue, which stains acetic mucins
and acid mucosubstances. Sections were deparaffinized and rehydrated in descending alcohol series
then incubated in 3% glacial acetic acid, followed by alcian blue (Sigma-Aldrich, Oakville, ON, Canada)
and 0.1% nuclear fast red counterstain (Electron Microscopy Sciences, Hatfield, PA, USA). Eight images
were randomly captured at 20× for each section (Leica DMIL LED inverted microscope, Wetzlar,
Germany; and QCapture Pro software, Surrey, BC, Canada). We first counted the number of alcian
blue positive cells (goblet cells) in one villus and one crypt nearest to the villus in each of the eight
images and took the average across the images to determine the mean number of goblet cells in a villus
and crypt for each animal. We also counted the number of alcian blue positive cells in two villi and two
crypts nearest to these villi in each of four images (randomly selected from the eight images). The total
number of epithelial cells in the same villi and crypts were also counted. The number of alcian blue
positive cells and total epithelial cells across the two villi and two crypts in each image were summed.
Then, the number of alcian blue positive cells and total epithelial cells were averaged across the four
images (separately for villi and crypts) to obtain the average number of goblet cells and epithelial cells
and the percentage of goblet cells per two villi or crypts for each animal. A researcher blinded to the
experimental groups performed the counting.
2.5. Data Analysis
Data were checked for normality using the Shapiro–Wilk test and equal variance using Levene’s
test. Outliers were excluded from analyses. Non-parametric data were transformed by applying either
logarithmic, square root, or cube root transformations. Differences between dietary groups for outcome
measures were analyzed using: (1) ANOVA with Tukey’s post hoc, (2) Kruskal–Wallis/Wilcoxon test
with Steel–Dwass post hoc for non-parametric data, or (3) Welch’s test with Games–Howell post hoc
for normal data with unequal variance (p < 0.05) using JMP 13 software (SAS Institute, Cary, NC,
USA). For qPCR and IHC data, biological replicates were CON n = 6–7 (n = 10–14 fetuses); UN n = 6–7
(n = 7–9 fetuses); and HF n = 7–8 (n = 13–15 fetuses). Data are shown as quantile box plots with 95%
confidence diamonds; p < 0.05.
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3. Results
3.1. Malnutrition Was Associated with Reduced Gut Barrier Function and Integrity
In UN mothers, SI mRNA expression levels of AMP genes Lyz2 (p = 0.02, Figure 1B) and Reg3g
(p = 0.003, Figure 1C) were decreased compared to CON. HF mothers had reduced mRNA expression
levels of Reg3g (p = 0.003, Figure 1C) and Muc2 (p = 0.001, Figure 1G) in SI compared to CON. There was
no effect of maternal diet on the expression of AMP genes Lyz1, Defa1, Defa5, and Pla2g2 (Figure 1A,D–F).
The average number of goblet cells, sites of mucus secretion, was higher in SI villi, but not crypts, of
UN mothers compared CON (Figure 2). Proportion of goblet cells relative to total number of epithelial
cells in both villi and crypts were not different between dietary groups (Figure 2).
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Figure 1. Maternal malnutrition was associated with altered gene expression of antimicrobial peptides
and mucin. Maternal UN was associated with decreased mRNA expression of antimicrobial peptide
genes Lyz2 (p = 0.02) and Reg3g (p = 0.003) vs. CON, while HF diet was associated with decreased Reg3g
(p = 0.003) and mucin (Muc2; p = 0.001) mRNA expression vs. CON (n = 6–8/group). Groups with
different letters are significantly different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
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Figure 2. Maternal malnutrition may influence small intestinal goblet cell number. (A) Staining of
goblet cells by alcian blue in small intestine (20× magnification). Arrows indicate goblet cells. Mean
number of goblet cells across 8 villi (B) or crypts (C). Mean percentage of goblet cells (proportion of
total number of epithelial cells) in villi (D) or crypts (E). There were a greater number of goblet cells in
UN villi vs. CON (p = 0.008; n = 6–8/group). Groups with different letters are significantly different
(p < 0.05). UN, undernourished; HF, high fat; CON, control.
3.2. Maternal HF Diet May Be Associated with Increased Lyz Production
Lyz protein was loc liz d to Pan th cells in the crypts of the maternal SI (Figure 3A). In the SI of
HF dams, semi-quantitative analyses revealed a significant reduction in the levels of low-intensity Lyz
staining (p = 0.03, Figure 3B) compared to CON, which may suggest an overall greater production
of this AMP in HF mothers. Further, an overall difference in moderate-intensity staining (p = 0.04;
Figure 3C) was detected, but there was no difference between groups with post hoc testing, and there
were no differences between diet groups in high- or strong-intensity staining levels (Figure 3D,E).
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Figure 3. Maternal HF diet was associated with less low-intensity lysozyme staining in intestinal crypts.
(A) Representative images of lysozyme protein immunoreactivity (ir) staining show localization to the
crypts of the maternal small intestine (SI) at d18.5, with negative control inset (40× magnification).
Arrows indicate lysozyme proteins within Paneth cells. (B–E) Lyz staining was quantified into
low, moderate, high, and strong intensities, representing increasing levels of protein expression
(n = 6–8/group). Semi-quantitative analysis revealed less low-intensity Lyz staining in SI from HF
mothers (p = 0.03) vs. CON, and an overall difference in moderate-intensity Lyz staining (p = 0.04),
but no difference between groups with post hoc testing. Groups with different letters are significantly
different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
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3.3. Maternal UN Was Associated with Delayed Fetal Gut Development and Reduced Mucus Production
UN, but not HF, fetuses showed increased mRNA expression of the gut transcription factor Sox9
(p = 0.02, Figure 4A) compared to CON, and an associated decrease in the mRNA expression levels of
Muc2 (p = 0.002, Figure 4B) and Cdx2 (p = 0.003, Figure 4C) compared to CON.
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Figure 4. UN fetuses displayed activation of a gut transcription factor that represses gut barrier
development and mucus production. Maternal UN was associated with increased fetal gut mRNA
expression of Sox9 (p = 0.02) vs. CON, and decreased Muc2 (p = 0.002) and Cdx2 (p = 0.003) vs. CON
(n = 8–15/group). Groups with different letters are significantly different (p < 0.05). UN, undernourished;
HF, high fat; CON, control.
3.4. Maternal HF Diet Was Associated with Increased Fetal EGC Development
Fetuses from HF-fed mothers had increased mRNA expression levels of EGC markers Bfabp (0.003,
Figure 5A) and S100b (p < 0.001, Figure 5B) compared to CON, and increased Plp1 (p = 0.04, Figure 5C)
compared to UN. There were no differences in gut mRNA expression levels of the EGC marker Sox10
and EGC neurotrophic factor Gdnf in fetuses exposed to different maternal diets (Figure 5D,E).
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Figure 5. HF fetuses showed activation of enteric glial cell markers in the gut. Maternal HF diet
was associated with increased fetal gut mRNA expression of enteric glial cells (EGC) markers S100b
(p < 0.001) and Bfabp (p = 0.003) vs. CON, and Plp1 (p = 0.04) vs. UN (n = 7–15/group). Groups with
different letters are significantly different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
3.5. Maternal HF Diet Was Associated with Increased Fetal Gut Barrier Function and Integrity
HF, but not UN, fetuses had increased mRNA expression levels of Paneth AMPs Lyz1 (p = 0.007,
Figure 6A), Reg3g (p = 0.01, Figure 6C), and Defa1 (p = 0.001, Figure 6D), and lower gut mRNA
expression levels of Tlr4 (p = 0.02, Figure 6E) compared to CON. No between-group differences were
detected in Lyz2 fetal gut mRNA expression levels (Figure 6B). Maternal HF diet was also associated
with an increase in fetal gut mRNA expression of TJ genes Cldn-3 (p = 0.008, Figure 7A) and Cldn-7
(p < 0.001, Figure 7B) compared to CON, while UN fetuses only displayed increased mRNA expression
of Cldn-7 compared to CON (p < 0.001, Figure 7B).
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Figure 6. HF fetuses showed an upregulation of gut barrier function genes and downregulation of
a microbe-sensing receptor. Maternal HF diet was associated with increased mRNA expression of
antimicrobial peptide (AMP) genes Lyz1 (p = 0.007), Reg3g (p = 0.01), and Defa1 (p = 0.001) in the fetal
gut vs. CON, though mRNA expression of the purported AMP-activating receptor Tlr4 was decreased
in these fetuses (p = 0.02) vs. CON (n = 9–15/group). Groups with different letters are significantly
different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
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Figure 7. Maternal malnutrition altered fetal gut tight junction gene expression. Maternal UN was
associated with increased mRNA expression of Cldn-7 (p < 0.001) in fetal gut vs. CON, while fetuses
from HF mothers increased Cldn-3 (p = 0.008) and Cldn-7 (p < 0.001) mRNA expression vs. CON
(n = 9–15/group). Groups with different letters are significantly different (p < 0.05). UN, undernourished;
HF, high fat; CON, control.
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3.6. Maternal Malnutrition Altered Fetal Gut mRNA Expression in Males More than in Females
Data on fetal outcomes were also stratified by sex (Figures 8–11). We found that maternal HF
diet was associated with increased mRNA expression of genes involved in EGC maturation (Bfabp,
Plp1, and S100b), gut barrier function (Lyz1 and Lyz2), and gut barrier integrity (Cldn-3 and Cldn-7) in
the male fetal gut (p < 0.05, Figures 9–11) compared to CON. Maternal HF diet was also associated
with reduced male fetal gut mRNA expression of the microbe-sensing toll-like receptor Tlr4 (p = 0.03,
Figure 10E) compared to CON. Male UN fetuses showed a reduction in fetal gut mRNA expression of
gut differentiation and maturation markers Cdx2 (p = 0.02, Figure 8B) and Muc2 (p < 0.001, Figure 8C),
and an upregulation of EGC marker Bfabp (p < 0.001, Figure 9A) and TJ gene Cldn-7 (p = 0.004,
Figure 11B).
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Figure 8. Maternal UN affected fetal gut barrier maturity in both sexes and mucus layer maturity in
male fetuses only. Maternal UN was associated with increased gut transcription factor Sox9 (p = 0.004)
vs. CON and decreased Cdx2 (p = 0.02) vs. HF in female fetal guts, and reduced Cdx2 (p = 0.02)
and Muc2 (p < 0.001) vs. CON in male fetal guts (n = 3–8/group). Groups with different letters are
significantly different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
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Figure 9. Maternal HF diet was associated with increased mRNA expression of enteric glial cell
markers in male fetuses. In male fetal guts, maternal HF diet was associated with increased Bfabp
(p < 0.001), S100b (p < 0.001), and Plp1 (p = 0.001), while maternal UN was associated with increased
Bfabp (p < 0.001). Maternal malnutrition (UN and HF) did not affect enteric glial cell development in
female fetal guts (n = 3–8/group). Groups with different letters are significantly different (p < 0.05). UN,
undernourished; HF, high fat; CON, control.
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Figure 10. Maternal HF diet was associated with increased expression of antimicrobial peptides and
decreased expression of microbe-sensing receptor in male fetuses. In male fetal guts, maternal HF
diet was associated with increased Lyz1 (p < 0.001) and Lyz2 (p < 0.001), and decreased Tlr4 (p = 0.03)
mRNA expression levels. Maternal malnutrition (UN and HF) did not affect Defa1 or Reg3g expression
levels in male fetuses or antimicrobial peptide levels in female fetal guts (n = 3–8/group). Groups with
different letters are significantly different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
Nutrients 2019, 11, 1375 15 of 24
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph Builder
Cldn-3 mRNA vs. FETAL SEX & D
FETAL SEX / DIE
CON DR HF CON DR HF
Female Male
Cl
dn
-3 
mR
NA
0.0
0.5
1.0
1.5
2.0
2.5
A Cldn-3 
a 
b 
ab 
CON UN HF 
Female 
CON UN HF 
Male 
a 
ab 
b 
N
or
m
al
iz
ed
 m
RN
A
 e
xp
re
ss
io
n 
2.  
2.  
1.  
1.  
0.  
0.  
Graph Builder
Cldn-7 mRNA vs. FETAL SEX & D
FETAL SEX / DIE
CON DR HF CON DR HF
Female Male
Cl
dn
-7 
mR
NA
0.5
1.0
1.5
2.0
CON UN HF 
Female 
CON UN HF 
Male 
B Cldn-7 
a 
b 
b 
2.0 
1.5 
1.0 
0.5 
Figure 11. Maternal malnutrition was associated with an increase in gut tight junction gene expression
in both fetal sexes. In male fetal guts, maternal HF diet was associated with increased Cldn-3 (p = 0.02)
and Cldn-7 (p = 0.004), while maternal UN was associated with increased Cldn-7 (p = 0.004); in
female fetal guts, maternal UN was associated with increased Cldn-3 (p = 0.03) mRNA expression
(n = 3–8/group). Groups with different letters are significantly different (p < 0.05). UN, undernourished;
HF, high fat; CON, control.
In female fetal guts, maternal UN was associated with increased mRNA expression of gut
differentiation transcription factor Sox9 (p = 0.004, Figure 8A) compared to CON, and decreased gut
maturation marker Cdx2 (p = 0.02, Figure 8B), though only compared to HF. Maternal UN was also
associated with increased TJ gene Cldn-3 (p = 0.03, Figure 11A) in female fetuses compared to CON.
4. Discussion
Despite the growing body of evidence linking the gut and its resident microbes to health [2,7],
few studies have investigated these relationships in the mother during pregnancy or the developing
fetus. Additionally, although we know that key enteric cells that support the gut barrier and establish
communication with the brain are laid down and functional in early life [49–51], we know less about
how early life nutritional adversity or altered gut microbes may influence their development and
function [52,53]. Since malnutrition is an important insult to pregnancies and their outcomes [54],
our study is the first to determine the effect of maternal malnutrition on maternal and fetal intestinal
barrier integrity and function, and its implications for fetal development.
Extensive research has demonstrated that high fat diets markedly alter the diversity
and composition of gut microbes [32,55–59], resulting in long-term aberrations in gut barrier
integrity [32,55–57,60] and function [32,55,61] and chronic inflammation [32,56,57]. As a result,
we hypothesized that mothers fed a HF diet would show pronounced changes in gut function.
We found that maternal HF diet was associated with reduced mRNA expression of Paneth cell AMP
Reg3g, which targets Gram-positive bacteria [62], no change in mRNA expression of AMPs Lyz1
and Lyz2, and less low-intensity Lyz staining, which may suggest an overall greater production of
Lyz protein, which can target both Gram-positive and Gram-negative bacteria [63]. These results
are analogous to those where HF feeding for 8 weeks in non-pregnant mice was associated with
a reduction in Reg3g SI mRNA expression and no expression changes in Lyz1 [61]. Maternal HF diet
was also associated with lower mRNA expression levels of the goblet cell-produced Muc2, which when
translated, becomes the main component of the mucus layer: the first line of defense against gut
infections and inflammation [64]. Although this was not associated with an increase in the number
of goblet cells in HF SI, our mRNA results align with a study where male and female mice fed a HF
diet from weeks 6–22 of life had a reduction in mRNA expression levels of Muc2 and cryptidins
(Paneth AMPs) [65]. Since Reg3g is critical to Muc2 distribution and spatial segregation of the
gut epithelium and bacteria [62,66,67], concurrent downregulation of these genes due to a HF diet
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may further alter the mucus layer and reduce gut barrier defenses against microbes, resulting in
bacterial contact with the epithelium, increased gut inflammation, gut tissue damage, and bacterial
translocation [62].
Similar to high fat diets, undernutrition is known to be a significant insult to gut barrier integrity
and function, increasing gut permeability [68–70], gut and peripheral inflammation [68,69], and bacterial
translocation [71], and altering gut barrier structure [72] and enteric cell function [73,74]. Despite this,
and to the best of our knowledge, our study is the first to investigate the effects of undernutrition on the
maternal gut barrier during pregnancy. We hypothesized that undernutrition would lead to adverse
changes in the maternal gut environment. We found that moderate maternal UN was associated
with lower mRNA expression levels of Paneth cell AMPs (Lyz2 and Reg3g), suggesting reduced gut
barrier function and ability to maintain gut-microbe homeostasis. This is consistent with findings
from a study where 48 h of starvation in non-pregnant mice led to a reduction in SI mRNA and
protein expression of Reg3g and Lyz, and a hyper-permeable barrier [33]. Since AMPs limit bacterial
contact with the gut barrier [75], a reduction in their expression has been associated with increased
bacterial adherence to the barrier [76] and bacterial translocation [1,33,77]. Moreover, AMPs have been
shown to block the release of IL-1β from activated immune cells [78], a pro-inflammatory cytokine
which exacerbates gut barrier permeability by creating gaps between TJ proteins [78–80]. These data
suggest that undernutrition may compromise the host’s ability to mount an appropriate immune
response through AMP pathways, resulting in increased susceptibility to infections and a leaky gut.
In fact, malnutrition is known to impair gut immune functioning, causing increased susceptibility to
environmental insults due to altered cytokine production [81]. This may be of particular concern in
pregnancies where undernutrition/underweight and infection often coexist, such as in populations
with low socioeconomic status [23,70]. Yet, even prior to bacteria reaching the gut barrier, a mucosal
layer produced by goblet cells provides protection. We found that UN mothers had an increased
number of villus-residing goblet cells, which may suggest an attempt to strengthen the gut barrier to
offset the consequences of reduced AMP expression, such as the heightened propensity for leaky gut.
Though early life development is key to setting healthy trajectories throughout life [82], little is
known about how perinatal events shape fetal gut development. Therefore, we were interested in
the effect of maternal malnutrition on fetal gut and ENS development and function. We focused on
the consequence of this nutritional adversity on genes involved in gut maturation and differentiation,
EGC development, Paneth AMP production, and TJ formation. Consistent with our hypothesis,
fetuses from HF mothers seemed to be most affected by an adverse nutritional exposure, as evidenced
by significantly altered expression levels of nine of the 15 genes tested. HF diet was associated with
changes in fetal EGC development, gut AMP production, and TJ expression. In fetuses from HF-fed
dams, we found increased mRNA expression of specific and widely-expressed [17,46,83] markers of
EGCs S100b, Bfabp, and Plp1, the latter of which to our knowledge has not been previously examined
in the mouse fetal gut. This increase in EGC markers may be in response to the higher inflammatory
environment in HF pregnancies that we have previously described [41], since EGCs are important for
regulating inflammatory pathways [84] and gut barrier integrity [20,84]. During intestinal inflammation
in adult animals, EGCs respond to pro-inflammatory signals and reverse inflammation-induced ENS
damage [85] by driving enteric neuron death through nitric oxide production [41,43,44] and triggering
ENS neurogenesis [86]. Previously, EGC proliferation was shown to occur in infant rats whose mothers
were fed HF diets perinatally, though mRNA and protein expression of local pro-inflammatory cytokines
were unchanged at all postnatal timepoints examined (2, 4, 6, and 12 weeks) [35]. Together with our
results, this may suggest that maternal HF diet exposure in utero may reprogram mechanisms in
the fetus that establish gut-brain connections and communication and increase EGC development to
reduce gut inflammation by the time of birth, thereby negating some of the fetal ENS damage incurred
during development. Future experiments should examine whether these changes in the fetal gut are
associated with altered brain development and function.
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Additionally, fetuses from HF mothers showed an increase in gut mRNA expression levels of AMP
genes Lyz1 (but not Lyz2), Defa1, and Reg3g. This is in contrast to studies in adult mice [27,32,55,65] that
have demonstrated that HF diets decrease gut levels of AMPs, though one study [29] found differing
results between the mRNA and protein levels. Nevertheless, our study is the first to our knowledge to
uncover how maternal malnutrition alters expression levels of AMPs in near-term fetuses and is the
first to assess Reg3g mRNA expression in fetal tissues. Due to the lack of other developed immune
mechanisms, fetuses may be increasing the expression of AMP genes to regulate and protect themselves
from the pro-inflammatory fetal environment observed in HF pregnancies [87–90]. In parallel to the
upregulation of AMPs, we observed reduced expression of Tlr4 mRNA in HF fetal gut, despite that,
at least in adult models, Tlr4 is known to initiate AMP production [91,92]. Nonetheless, depending on
tissue type, the same TLR can downregulate, upregulate, or not affect AMP production [93], adding to
the complexity of the TLR-AMP relationship which is further compounded by the lack of work on TLR
function in fetal gut tissue.
In mammals, 24 members of the claudin family exist, each with unique charge-selectivity
preferences that dictate barrier permeability and tight junction structure and function [94]. Of the
claudin family, Cldn-3 and Cldn-7 are the amongst the most highly expressed in all sections of the mouse
GI tract [95]. Cldn-3 has previously been shown to be affected by HF diets [60] and commensal bacterial
colonization [96], while Cldn-7 has been found to have functions outside of barrier integrity, such as
maintenance of intestinal homeostasis [97], and both its mRNA and protein are highly expressed in the
small and large intestine [97]. Still, expression levels of neither Cldn-3 nor Cldn-7 have been recorded
in mouse fetal guts. In our study, fetuses from HF mothers showed an increase in mRNA expression of
both TJs Cldn-3 and Cldn-7, however these data run counter to the effects of HF diets on TJ expression
in adult mice and rats [56,57,60]. Research on the ontogeny and development of tight junction proteins
in the fetal mouse gut is scarce, though in human fetuses, tight junction proteins appear at 8–10 weeks
of gestation and begin to assemble junctional complexes (continuous, belt-like structures around cells)
at 10–12 weeks [98]. Nevertheless, most of the development of the tight junction proteins and gut
integrity occurs in postnatal life [94], indicating that the prenatal fetal gut may be particularly sensitive
and vulnerable to the effects of adverse in utero exposures due to a permeable gut barrier. As HF
fetuses showed increased expression of TJ proteins, which is consistent with their increased expression
of EGC markers, it may be that HF fetuses are compensating for a highly inflammatory maternal
environment by tightening the gut barrier.
Similar to HF fetuses, we hypothesized that fetal growth restriction would lead to aberrant gut
barrier development in fetuses from UN mothers. Accordingly, we found that UN fetuses had increased
expression of the gut transcription factor Sox9, which is known to repress the expression of Muc2 and
Cdx2 through activation of the Wnt-β-Catenin-TCF4 pathway [99], and reduced mRNA expression of
mucus (Muc2) and gut differentiation (Cdx2) genes. These data are indicative of immature gut barrier
development, and consistent with the reduced weight of these fetuses compared to CON and HF
fetuses. Importantly, an immature gut may be associated with increased susceptibility to inflammatory
and infectious insults, due to reduced gut barrier integrity and function, gut dysbiosis [100–102],
and irreversible [103] aberrant nutrient absorption [103–106]. This has long-term implications for
growth-restricted offspring, including those born too soon, such as preterm infants, who are at
greater risk for necrotizing enterocolitis [107–109] and nutrient malabsorption [103,105,106] due to
poor gut development and function. Despite the changes in gut maturation and mucus production,
fetuses from UN mothers showed an increase in gut Cldn-7, but not Cldn-3, mRNA expression,
which might suggest an attempt to increase barrier integrity to compensate for the gut barrier
immaturity. Lastly, our sex-stratified data suggest that the majority of observed group differences
were driven by male fetuses, which is consistent with numerous reports which demonstrate that male
fetuses are more susceptible to perinatal insults, especially due to maternal malnutrition [110–115].
One limitation of our study is our focus on gene expression, especially in fetal samples where
sample volume is extremely limited. Findings from qPCR data can direct future experiments that
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examine changes at the protein level. Another limitation is the low n-number in the female fetal
UN group; thus, sex-stratified changes in mRNA expression should be interpreted with caution.
Lastly, although our study is cross-sectional, we focused on an important developmental time (d18.5)
that can serve as an indicator of embryonic/fetal experiences and provide information that could
explain neonatal development and adaptations. Future studies should examine when changes in
Paneth cell and EGC development and function are initiated in the pregnant mother and developing
offspring, and how long they persist, which could point to critical windows for intervention to correct
adverse health and developmental trajectories set by malnutrition.
5. Conclusions
Our study is the first to examine the effect of both over- and undernutrition in parallel,
during gestation in mice, and reveal the impact of maternal malnutrition on fetal gut Paneth cell
function and EGC development—cells vital for gut barrier function and gut-brain axis connection.
Our results indicate that malnutrition before and during gestation has adverse consequences for fetal
gut development, maternal and fetal gut function, and potentially long-term programming of gut
and brain function and gut immunity. If our findings are applicable to humans, this work may help
inform research on dietary interventions that aim to prevent or mitigate the effects of being exposed to
suboptimal nutrition in pregnancy (for mothers) and in early life (for offspring). Future work should
place special focus on vulnerable populations wherein malnutrition and infection are more likely to
coexist during pregnancy, exacerbating the negative repercussions of both noxious states on maternal
and offspring wellbeing.
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